tiprankstipranks
NewAmsterdam Pharma Company (NAMS)
NASDAQ:NAMS
US Market

NewAmsterdam Pharma Company (NAMS) Cash flow

72 Followers

NewAmsterdam Pharma Company Cash Flow

NAMS's free cash flow for Q was $―. For the fiscal year, NAMS's free cash flow was decreased by $-149.20M and operating cash flow was $―. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -566.28K$ -141.22M$ 7.97M$ -138.38K$ -500.00K
Investing Cash Flow
-$ -24.00K$ 715.00K$ 0.00$ -138.00M
Financing Cash Flow
$ -45.00K$ 8.91M$ 375.18M$ 0.00$ 139.87M
Cash Flow From Discontinued Operation
-----
Other Cash Adjustment Inside Changein Cash
-----
End Cash Position
$ 1.40M$ 340.45M$ 59.18M$ 1.23M$ 1.37M
Income Tax Paid Supplemental Data
-$ 27.00K---
Interest Paid Supplemental Data
-----
Issuance Of Capital Stock
---$ 0.00$ 143.01M
Issuance Of Debt
--$ -65.00K--
Repayment Of Debt
--$ -65.00K$ 0.00$ -82.91K
Free Cash Flow
$ -566.28K$ -141.24M$ 7.96M$ -138.38K$ -500.00K
Domestic Sales
-----
Foreign Sales
-----
Currency in USD

NewAmsterdam Pharma Company Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis